An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia.

Area of Science:

• Proteomics
• Biochemistry
• Obstetrics

Background:

• Preeclampsia is a significant pregnancy complication causing preterm birth and fetal growth restriction.
• Currently, no definitive diagnostic test exists for preeclampsia.
• Identifying reliable biomarkers is crucial for early detection and management.

Purpose of the Study:

• To identify novel serum/plasma biomarkers for preeclampsia using a proteomic approach.
• To investigate potential mechanistic links between identified biomarkers and preeclampsia pathophysiology.
• To explore the association between preeclampsia and subsequent cardiovascular disease.

Main Methods:

• Case-control study comparing nulliparous women with and without preeclampsia.
• Proteomic analysis of serum/plasma using 2D gel electrophoresis and difference gel electrophoresis.
• Protein identification via mass spectrometry and validation through immunoblotting.

Main Results:

• Identified several proteins associated with preeclampsia, including apolipoprotein E (apoE), apoC-II, complement factor C3c, fibrinogen, transthyretin, and complement factor H-related protein 2.
• Detected altered isoforms of apolipoprotein E3 in preeclamptic plasma.
• Confirmed changes in apoE isoforms using immunoblotting.

Conclusions:

• Novel serum biomarkers for preeclampsia have been identified.
• Altered apolipoprotein E isoforms may contribute to arterial damage and link preeclampsia to cardiovascular disease.
• These findings suggest new avenues for preeclampsia diagnosis and understanding its long-term health implications.